BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jha NK, Sharma C, Hashiesh HM, Arunachalam S, Meeran MN, Javed H, Patil CR, Goyal SN, Ojha S. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Front Pharmacol 2021;12:590201. [PMID: 34054510 DOI: 10.3389/fphar.2021.590201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chapman RL, Andurkar SV. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19. Med Chem Res 2021;:1-12. [PMID: 34873386 DOI: 10.1007/s00044-021-02826-2] [Reference Citation Analysis]
2 Wang JB, Andrade-Cetto A, Echeverria J, Wardle J, Yen HR, Heinrich M. Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic. Front Pharmacol 2021;12:798674. [PMID: 34925048 DOI: 10.3389/fphar.2021.798674] [Reference Citation Analysis]
3 Janecki M, Graczyk M, Lewandowska AA, Pawlak Ł. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. IJMS 2022;23:4170. [DOI: 10.3390/ijms23084170] [Reference Citation Analysis]
4 Lesnic A, Haj Hamoud B, Poenaru MO, Moldovan VT, Chicea R, Sima RM, Popescu M, Ples L. Can SARS-CoV-2 Induce Uterine Vascular Anomalies and Poor Contractile Response?-A Case Report. Medicina (Kaunas) 2021;57:670. [PMID: 34209533 DOI: 10.3390/medicina57070670] [Reference Citation Analysis]
5 Mödinger Y, Knaub K, Dharsono T, Wacker R, Meyrat R, Land MH, Petraglia AL, Schön C. Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS). Molecules 2022;27:2860. [DOI: 10.3390/molecules27092860] [Reference Citation Analysis]